The interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is recognised for augmenting HCC production by improving interferon-alpha (IFN α) effector signaling, hence promoting IFN α effector responses and treatment efficacy (Yang et al., 2017). Here, IFNA1 is linked to hepatocellular carcinoma.